Skip Navigation

Correction for Johnson, J. Natl. Cancer Inst. 95 (19) 1422-1424.
JNCI Journal of the National Cancer Institute 2003 95(22):1728;
© 2003 by Oxford University Press
This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2003 Oxford University Press

Erratum

Erratum: "Adjuvant Chemotherapy for Non-Small-Cell Lung Cancer: The End of the Beginning" by Johnson [J Natl Cancer Inst 2003;95:1422–4(Issue 19)]. On page 1422, the first full sentence in the second column should read "Consequently, patients with stage IA NSCLC have been excluded from other adjuvant studies (i.e., CAN NCIC BR10, which closed to patient accrual in 2001, and CLB-9633, which remains open to accrual; http://www.nci.nih.gov/search/ clinical_trials/search_clinicaltrialsadvanced. aspx)."


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?